Tenderwize
Back to tender search

Non-exclusive discount agreement for Propofol (N01AX10)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 674 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Propofol (ATC-Code: N01AX10).

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

25 / 100

Risk factors

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Enter into a non-exclusive discount agreement for the active ingredient Propofol (ATC N01AX10) for physician’s office supplies in Lower Saxony.
  • The agreement is under an open-house model: all qualified pharmaceutical entrepreneurs may join on identical terms, with no selection or negotiation.
Show full summary

This is an open-house non-exclusive discount agreement (Rabattvertrag) for the active ingredient Propofol (ATC: N01AX10) for physician's office supplies (Sprechstundenbedarf) in Lower Saxony, Germany. The contracting authority is AOK Niedersachsen. The agreement is not a public procurement but a transparent open-house model where all qualified pharmaceutical entrepreneurs can join. The agreement period is from 01.09.2026 to 31.08.2028, with rolling entry possible on the first of each month. The first deadline for initial contracts is 28.07.2026. No estimated value is provided.

Risks

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4(18) AMG or a consortium of such entrepreneurs.
  • Must have a registered seat in Germany, an EU member state, or an EEA state.
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs.

Requirements may be incomplete.

Buyer

Location

Hannover, DEU

Identifier

AOK- Niedersachsen. Die Gesundheitskasse

Activity

Health

Lots (1)

LOT-0000

Non-exclusive discount agreement for Propofol (N01AX10)

This lot covers the conclusion of non-exclusive discount agreements for Propofol preparations in Lower Saxony under the open-house model. All interested pharmaceutical entrepreneurs can join with uniform conditions. No selection or competition.

SuppliesFrameworkEU fundedElectronic submission

Location

DE929, Germany

Duration

Aug 2026 - Aug 2028

Category

Pharmaceutical products

Deadline

Deadline Jun 27, 2028

Procurement Details

Publication date
05 Jul 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
460781-2026

Similar tenders